arrow
J

José Antonio López-Guerrero

Universidad Autonoma de Madrid
H指数:45
被引数:9,305

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of a Baloxavir-Inspired Endonuclease Inhibitor That Prevents Herpes Simplex Virus 1 Replication in Cell Culture and In Vivo

一种能预防单纯疱疹病毒1型在细胞培养和体内复制的Baloxavir启发型的核酸内切酶抑制剂的发现

2025-09-150
OAAI
Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): an open-label, single-arm, phase 2 trial

预防曲拉鲁单抗govitecan相关中性粒细胞减少症和腹泻在HER2阴性晚期乳腺癌患者中的效果(PRIMED):一项开放标签、单臂、Ⅱ期临床试验

2025-07-010
PRE
Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcoma
2024-11-040
OAAI
Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab
2024-03-082
OA
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial

REGISTRI: KIT/PDGFRA野生型转移性GIST的一线Regorafenib: 西班牙 (GEIS),意大利 (ISG) 和法国肉瘤组 (FSG) II期临床试验

2023-08-099
OAAI
Extraskeletal myxoid chondrosarcoma: p53 and Ki-67 offer prognostic value for clinical outcome - an immunohistochemical and molecular analysis of 31 cases

骨骼外黏液样软骨肉瘤: p53和Ki-67为临床结果提供预后价值-31例的免疫组织化学和分子分析

2022-11-143
PRE
Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study
2022-11-042
OAAI